glp 1 agonist and dementia Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline in Diabetes Mellitus GLP-1 and Alzheimer's Disease: Research

A clinical trial in 2015 linked an undisclosed GLP-1 to significant improvements in OSA severity, while a 2016 clinical trial found that weight loss resulting from liraglutide was significantly associated with a reduction in the apnea-hypopnea index (AHI)

Generally safe when prescribed by a doctor and monitored regularly

Lilly USA, LLC

Long term loss of muscle mass has been associated with osteoporosis and other health issues

Need Help

A doctor may consider the following factors: your medical history your health concerns what other medications youre taking They can also provide more information about insurance coverage and how much you can expect to pay out of pocket for your prescription